n-methyl-3,4-methylenedioxyamphetamine has been researched along with concanavalin a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Connor, TJ; Currid, A; Finn, D; Kelly, JP; Leonard, BE; McNamara, MG; O'Malley, M; Redmond, AM | 1 |
Connor, TJ; Kelly, JP; Leonard, BE | 1 |
2 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and concanavalin a
Article | Year |
---|---|
Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces a rapid and sustained suppression of immune function in the rat.
Topics: Animals; Cerebral Cortex; Concanavalin A; Corticosterone; Female; Hallucinogens; Hydroxyindoleacetic Acid; Immunity, Cellular; Leukocyte Count; Lymphocyte Activation; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; T-Lymphocytes; Time Factors | 1998 |
An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Concanavalin A; Cytokines; Female; Fenfluramine; Immunity; Leukocyte Count; Lipopolysaccharides; Lymphocyte Activation; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Agents | 2000 |